An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.

Guests

  • Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
  • Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
  • William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Maya Angelou: “Mom & Me & Mom” (Rebroadcast) – And Diane Signs Off

Friday, Dec 30 2016Maya Angelou came onto this program several times over the years. But in her last conversation with Diane, in 2013, she talked about writing about her fraught relationship with her mother for the first time. Her last words to Diane: “I love you, Diane Rehm. And I look forward to seeing you and talking to you again and again.” A year later, she died at the age of 86. In one of Diane's most treasured interviews, the women reflect on forgiveness, healing and reconciliation.